Otto Bremer Trust - 26 Feb 2026 Form 4 Insider Report for OLD NATIONAL BANCORP /IN/ (ONB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2026, 16:22:13 UTC
Prior SEC filing
07 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel C. Reardon (Co-CEO and Trustee of Otto Bremer Trust)

Key filing fact

Otto Bremer Trust filed Form 4 for OLD NATIONAL BANCORP /IN/ (ONB) on 02 Mar 2026.

Key facts

  • This page summarizes Otto Bremer Trust's Form 4 filing for OLD NATIONAL BANCORP /IN/ (ONB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2026, 16:22.

Change

  • Previous filing in this sequence was filed on 07 May 2025.
  • Current net transaction value: -$49,999,993.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002064726 Primary reporting owner

Otto Bremer Trust

Relationship
10%+ Owner
Address
30 E 7TH ST STE 2900, ST. PAUL
Signature
/s/ Daniel C. Reardon (Co-CEO and Trustee of Otto Bremer Trust)
Signature date
02 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONB transaction

Common Stock

Sale

Transaction value
$49,999,993
Shares
-1,926,782
Change %
-4.5%
Price
$25.95
Shares after
41,210,548
Date
26 Feb 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Shares of common stock of the Issuer (the "Shares") sold pursuant to an agreement between the Issuer and the trustees of the Reporting Person (the "Trustees"), at a purchase price of $25.95 per Share, which per Share price was agreed upon between the Issuer and the Trustees on February 11, 2026, based on the range of intraday trading prices for the Issuer's common stock on the NASDAQ Stock Exchange on that date. The sale of the Shares closed on February 26, 2026. The Shares were sold for investment portfolio diversification purposes of the Reporting Person.

Footnote F2

The Reporting Person has three Trustees. Any action by the Reporting Person with respect to the shares of Common Stock may be taken only by majority vote of the Trustees and, therefore, no Trustee individually has voting or dispositive power with respect to the shares.

SEC remarks

Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be a director-by-deputization by virtue of the Reporting Person's one-time contractual right to designate a Trustee for appointment to the board of directors of the Issuer pursuant to the Investor Agreement by and between the Trustees and the Issuer, dated November 25, 2024, under which the Issuer appointed one of the Trustees as a director of the Issuer, effective May 1, 2025, to serve in accordance with the corporate governance guidelines and standards applicable to all Issuer directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .